ArticleBMC bioinformatics2021
Boosting scRNA-seq data clustering by cluster-aware feature weighting.
Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data.Annals of translational medicine · 2022Article
- Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.Clinical and translational medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe rapid development of single-cell RNA sequencing (scRNA-seq) enables the exploration of cell heterogeneity, which is usually done by scRNA-seq data clustering. The essence of scRNA-seq data clustering is to group cells by measuring the similarities among genes/transcripts of cells. And the selection of features for cell similarity evaluation is of great importance, which will significantly impact clustering effectiveness and efficiency.
resultsIn this paper, we propose a novel method called CaFew to select genes based on cluster-aware feature weighting. By optimizing the clustering objective function, CaFew obtains a feature weight matrix, which is further used for feature selection. The genes have large weights in at least one cluster or the genes whose weights vary greatly in different clusters are selected. Experiments on 8 real scRNA-seq datasets show that CaFew can obviously improve the clustering performance of existing scRNA-seq data clustering methods. Particularly, the combination of CaFew with SC3 achieves the state-of-art performance. Furthermore, CaFew also benefits the visualization of scRNA-seq data.
conclusionCaFew is an effective scRNA-seq data clustering method due to its gene selection mechanism based on cluster-aware feature weighting, and it is a useful tool for scRNA-seq data analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.